Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Diabetes

Date Submitted: May 2, 2024
Date Accepted: Apr 14, 2025

The final, peer-reviewed published version of this preprint can be found here:

Estimating the Risk of Lower Extremity Complications in Adults Newly Diagnosed With Diabetic Polyneuropathy: Retrospective Cohort Study

Adams A, Lee C, Escobar G, Bayliss E, Callaghan B, Horberg M, Schmittdiel J, Trinacty C, Gilliam L, Kim E, Hejazi N, Ma L, Neugebauer R

Estimating the Risk of Lower Extremity Complications in Adults Newly Diagnosed With Diabetic Polyneuropathy: Retrospective Cohort Study

JMIR Diabetes 2025;10:e60141

DOI: 10.2196/60141

PMID: 40440641

PMCID: 12140504

Estimating the Risk of Lower Extremity Complications in Adults Newly Diagnosed with Diabetic polyneuropathy: A Retrospective Cohort Study

  • Alyce Adams; 
  • Catherine Lee; 
  • Gabriel Escobar; 
  • Elizabeth Bayliss; 
  • Brian Callaghan; 
  • Michael Horberg; 
  • Julie Schmittdiel; 
  • Connie Trinacty; 
  • Lisa Gilliam; 
  • Eileen Kim; 
  • Nima Hejazi; 
  • Lin Ma; 
  • Romain Neugebauer

ABSTRACT

Background:

Lower extremity complications related to diabetic polyneuropathy (DPN) are under- detected and on the rise in the U.S. Clinical decision tools are needed to identify people at high risk for these complications.

Objective:

To determine if a machine learning enabled algorithm could adequately predict which patients were at highest risk for lower extremity complications within 24 months of an initial neuropathy diagnosis.

Methods:

The study was conducted across two large multispecialty healthcare systems in northern California and Colorado. We included 48,209 insured adults with a new DPN diagnosis (04/01/2012-12/31/2016) who were not near end-of-life in the 24 months before diagnosis. The outcome was assessed using a composite indicator for any diagnoses consistent with lower extremity complications (foot ulceration, osteomyelitis, gangrene, lower extremity amputation) occurring within 24 months of DPN diagnosis.

Results:

Lower extremity complications, primarily foot ulcerations, occurred in 4.8% of individuals. The SL risk estimator exhibited good discrimination (area under the Receiver Operating Characteristic curve (ROC): 0.845 [0.826, 0.863]) and calibration and outperformed a naïve logistic regression model using complete cases only (area under ROC: 0.804 [0.783, 0.825]). A modified SL algorithm, simplified to facilitate real-world adoption, had only slightly reduced discrimination (area under ROC: 0.817 [0.797, 0.837]) and outperformed the naïve logistic regression model in terms of precision gained relative to the frequency of alerts and number of patients needed to evaluate.

Conclusions:

A risk estimator for DPN-related lower extremity events exhibited good predictive accuracy and strong potential for clinical application. Additional research is needed to identify optimal contexts for deployment and strategies for maximizing algorithmic fairness.


 Citation

Please cite as:

Adams A, Lee C, Escobar G, Bayliss E, Callaghan B, Horberg M, Schmittdiel J, Trinacty C, Gilliam L, Kim E, Hejazi N, Ma L, Neugebauer R

Estimating the Risk of Lower Extremity Complications in Adults Newly Diagnosed With Diabetic Polyneuropathy: Retrospective Cohort Study

JMIR Diabetes 2025;10:e60141

DOI: 10.2196/60141

PMID: 40440641

PMCID: 12140504

Per the author's request the PDF is not available.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.